Evidence map›Paper›PMID 31021991›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.

Monica Gandhi, Laura M Smeaton, Christina Vernon, Eileen P Scully, Sara Gianella, Selvamuthu Poongulali, Anandi N Sheth, Marije Van Schalkwyk, Karin L Klingman, William R Short and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  5. The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living With or at Risk for Human Immunodeficiency Virus Infection in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Monica GandhiUniversity of California San Francisco, San Francisco, CA.
Laura M SmeatonHarvard T.H. Chan School of Public Health, Boston, MA.
Christina VernonSocial & Scientific Systems, Silver Spring, MD.
Eileen P ScullyJohns Hopkins University, Baltimore, MD.
Sara GianellaUniversity of California San Diego, La Jolla, CA.
Selvamuthu PoongulaliYR Gaitonde Center for AIDS Research and Education, Chennai, India.
Anandi N ShethEmory University, Atlanta, GA.
Marije Van SchalkwykStellenbosch University, Cape Town, South Africa.
Karin L KlingmanNIH, Bethesda, MD.
William R ShortUniversity of Pennsylvania, Philadelphia, PA.
Valarie S OpolloKenya Medical Research Institute, Kisumu, Kenya.
Susan E CohnNorthwestern University, Chicago, IL.
Kimberly K ScarsiUniversity of Nebraska Medical Center, Omaha, NE.
Cindy FirnhaberUniversity of Colorado, Aurora, CO.
Sara BaresUniversity of Nebraska, Omaha, NE.
Shobha SwaminathanRutgers New Jersey Medical School, Newark, NJ.
Rosie MngqibisaEnhancing Care Foundation, Durban, South Africa.
Elizabeth ConnickUniversity of Arizona, Tucson, AZ.
Womenʼs Health Inter-Network Scientific Committee (WHISC)

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
Statistical and Data Management Center for the AIDS Clinical Trials GroupU01AI068634 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUGHES, MICHAEL DAVID · 2006 to 2010
$71.9M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Mohamed Abdel Mohsen · 2015 to 2026
$38.4M
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplicationUM1AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI REES, HELEN, SANNE, IAN MATTHIAS · 2012 to 2025
$31.8M
Northwestern University Clinical Trial UnitUM1AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach · 2012 to 2026
$24.6M
Units for HIV/AIDS Clinical Trials NetworksU01AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI SANNE, IAN MATTHIAS · 2007 to 2011
$24.2M
Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaUM1AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI Shaun Barnabas, Anneke Catharina Hesseling · 2012 to 2026
$21.5M
Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaU01AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI COTTON, MARK FREDRIC · 2007 to 2011
$8.4M
NIAID NIH HHS K23 AI114407NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI117943NIAID NIH HHS R01 AI098472NIAID NIH HHS R01 AI143340NIAID NIH HHS R37 AI098472NIAID NIH HHS U01 AI068634NIAID NIH HHS U01 AI069463NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069463NIAID NIH HHS UM1 AI069471NIAID NIH HHS UM1 AI069521NIAID NIH HHS UM1 AI106701NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AIDS-Related Opportunistic InfectionsSex CharacteristicsAnimalsAnti-HIV AgentsFemaleHIV InfectionsHumansMaleAnti-HIV Agents

Identifiers

PMID31021991
PMCPMC6625875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.